Fluoxetine and S-citalopram inhibit M1 activation and promote M2 activation of microglia in vitro

Neuroscience

Volumn 294, Issue , 2015, Pages 60-68

  Su, F ^a   Yi, H ^a   Xu, L ^b   Zhang, Z ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

Author keywords

Depression; Fluoxetine; Microglia; S citalopram

Indexed keywords

CD86 ANTIGEN; CITALOPRAM; FLUOXETINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; ANTIDEPRESSANT AGENT; CYTOKINE; SEROTONIN UPTAKE INHIBITOR;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; IMMUNOMODULATION; IN VITRO STUDY; MACROPHAGE ACTIVATION; MICROGLIA; MICROGLIAL CELL CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; DRUG EFFECTS; METABOLISM;

ANIMALS; ANTIDEPRESSIVE AGENTS; CELLS, CULTURED; CITALOPRAM; CYTOKINES; FLUOXETINE; MICE; MICROGLIA; SEROTONIN UPTAKE INHIBITORS;

EID: 84925643115     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.02.028     Document Type: Article

References (48)

1. Aloisi F. Immune function of microglia. Glia 2001, 36(2):165-179.
2. Arakawa S., et al. Minocycline produced antidepressant-like effects on the learned helplessness rats with alterations in levels of monoamine in the amygdala and no changes in BDNF levels in the hippocampus at baseline. Pharmacol Biochem Behav 2012, 100(3):601-606.
3. Barrientos R.M., et al. Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience 2003, 121(4):847-853.
4. Basterzi A.D., et al. IL-6 levels decrease with SSRI treatment in patients with major depression. Hum Psychopharmacol 2005, 20(7):473-476.
5. Ben M.O., et al. Intrahippocampal transplantation of transgenic neural precursor cells overexpressing interleukin-1 receptor antagonist blocks chronic isolation-induced impairment in memory and neurogenesis. Neuropsychopharmacology 2008, 33(9):2251-2262.
6. Burke N.N., et al. Minocycline modulates neuropathic pain behaviour and cortical M1-M2 microglial gene expression in a rat model of depression. Brain Behav Immun 2014, 42:147-156.
7. Capuron L., Miller A.H. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 2011, 130(2):226-238.
8. Colton C., Wilcock D.M. Assessing activation states in microglia. CNS Neurol Disord: Drug Targets 2010, 9(2):174-191.
9. Dahl J., et al. The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery. Psychoneuroendocrinology 2014, 45:77-86.
10. Dowlati Y., et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010, 67(5):446-457.
11. Du R.W., Du R.H., Bu W.G. Beta-arrestin 2 mediates the anti-inflammatory effects of fluoxetine in lipopolysaccharide-stimulated microglial cells. J Neuroimmune Pharmacol 2014, 9(4):582-590.
12. Eyre H.A., Stuart M.J., Baune B.T. A phase-specific neuroimmune model of clinical depression. Prog Neuropsychopharmacol Biol Psychiatry 2014, 54:265-274.
13. Fujigaki H., et al. The signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways, and synergistic effect of several proinflammatory cytokines. J Biochem 2006, 139(4):655-662.
14. Ha E., et al. Fluoxetine increases the nitric oxide production via nuclear factor kappa B-mediated pathway in BV2 murine microglial cells. Neurosci Lett 2006, 397(3):185-189.
15. Hannestad J., DellaGioia N., Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 2011, 36(12):2452-2459.
16. Hashioka S., et al. Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Exp Neurol 2007, 206(1):33-42.
17. Hinwood M., et al. Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex. Cereb Cortex 2012, 22(6):1442-1454.
18. Horikawa H., et al. Inhibitory effects of SSRIs on IFN-gamma induced microglial activation through the regulation of intracellular calcium. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34(7):1306-1316.
19. Hu F., Pace T.W., Miller A.H. Interferon-alpha inhibits glucocorticoid receptor-mediated gene transcription via STAT5 activation in mouse HT22 cells. Brain Behav Immun 2009, 23(4):455-463.
20. Iosif R.E., et al. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J Neurosci 2006, 26(38):9703-9712.
21. Jiang H., Harris M.B., Rothman P. IL-4/IL-13 signaling beyond JAK/STAT. J Allergy Clin Immunol 2000, 105(6 Pt. 1):1063-1070.
22. Kettenmann H., et al. Physiology of microglia. Physiol Rev 2011, 91(2):461-553.
23. Kitamura Y., et al. Interleukin-4-inhibited mRNA expression in mixed rat glial and in isolated microglial cultures. J Neuroimmunol 2000, 106(1-2):95-104.
24. Kobayashi K., et al. Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis 2013, 4:e525.
25. Krishnadas R., Cavanagh J. Depression: an inflammatory illness?. J Neurol Neurosurg Psychiatry 2012, 83(5):495-502.
26. Lee C.H., et al. Pre- and post-treatments with escitalopram protect against experimental ischemic neuronal damage via regulation of BDNF expression and oxidative stress. Exp Neurol 2011, 229(2):450-459.
27. Lim C.M., et al. Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect. J Neurosci Res 2009, 87(4):1037-1045.
28. Liu D., et al. Anti-inflammatory effects of fluoxetine in lipopolysaccharide (LPS)-stimulated microglial cells. Neuropharmacology 2011, 61(4):592-599.
29. Lo F.S., et al. Outcome of psychiatric symptoms presenting at onset of multiple sclerosis: a retrospective study. Mult Scler 2010, 16(6):742-748.
30. Miller A.H., Pariante C.M., Pearce B.D. Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression. Adv Exp Med Biol 1999, 461:107-116.
31. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009, 65(9):732-741.
32. Miyaoka T., et al. Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry 2012, 37(2):222-226.
33. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308(5726):1314-1318.
34. Raison C.L., Miller A.H. Is depression an inflammatory disorder?. Curr Psychiatry Rep 2011, 13(6):467-475.
35. Rizzo F., et al. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis. Cell Mol Life Sci 2014, 71(6):999-1015.
36. Rogers J., et al. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?. Int Rev Neurobiol 2007, 82:235-246.
37. Roumestan C., et al. Anti-inflammatory properties of desipramine and fluoxetine. Respir Res 2007, 8:35.
38. Saijo K., Glass C.K. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 2011, 11(11):775-787.
39. Salemi J., et al. Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD). Mol Neurodegener 2011, 6(1):3.
40. Steiner J., et al. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?. J Neuroinflammation 2011, 8:94.
41. Taylor R.A., Sansing L.H. Microglial responses after ischemic stroke and intracerebral hemorrhage. Clin Dev Immunol 2013, 2013:746068.
42. Torres-Platas S.G., et al. Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav Immun 2014, 42:50-59.
43. Tuglu C., et al. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology 2003, 170(4):429-433.
44. Tynan R.J., et al. A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun 2012, 26(3):469-479.
45. Varnum M.M., Ikezu T. The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain. Arch Immunol Ther Exp (Warsz) 2012, 60(4):251-266.
46. Wichers M., Maes M. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol 2002, 5(4):375-388.
47. Yang W., et al. Altered RNA editing of serotonin 5-HT2C receptor induced by interferon: implications for depression associated with cytokine therapy. Brain Res Mol Brain Res 2004, 124(1):70-78.
48. Zhu C.B., Blakely R.D., Hewlett W.A. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 2006, 31(10):2121-2131.